XOMA Shares Climb 8.6% (XOMA, NVG, MRK)

Shares of XOMA Ltd. XOMA are trading up 8.6% at $5.54 per share during the Thursday afternoon trading session. The day's range for shares of XOMA Ltd has been between $5.10 and $5.84 per share. The average price target of analysts who cover XOMA Ltd. (XOMA) is $8.18 per share. Volume of 8.5 million shares is already more than 4 times the daily average volume of 1.9 million shares. XOMA Ltd discovers, develops and manufactures novel antibody therapeutics for its own proprietary pipeline as well as through license and collaborative agreements with pharmaceutical and biotechnology companies, and under its contracts with the U.S. government. In addition to its proprietary pipeline, XOMA Ltd develops products with premier pharmaceutical companies including Novartis AG NVS, Schering Corporation, a subsidiary of Merck & Company, Inc. MRK and Takeda Pharmaceutical Company Limited. Read more from Benzinga's Company news.